Compare CVS Health Corp (CVS) vs Oracle Corporation (ORCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Oracle Corporation — how do they compare? CVS Health Corp trades at $104.88 (market cap $135.48B), while Oracle Corporation trades at $129.81 (market cap $368.53B). The key difference: Oracle Corporation is far larger — about 2.7× CVS Health Corp's market cap, and CVS Health Corp pays the higher dividend (2.51%). Which is the better fit depends on your goals.
| CVS | ORCL | |
|---|---|---|
Market Cap | $135.48B | $368.53B |
Sector | Health | Technology |
52-Week High | $106.18 | $328.33 |
52-Week Low | $58.75 | $127.96 |
Enterprise Value | $202.02B | $497.78B |
Dividend Yield | 2.51% | 1.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Oracle Corporation (ORCL) is trading at $127.96, down 9.04% today, reflecting recent market volatility. The stock shows strong fundamentals with consistent earnings beats (Q1 2026 EPS of $2.11 vs. $1.96 expected) and robust profitability (net margin of 25.37%). Technical indicators are bearish with support at $124, while analyst consensus remains bullish with a $259 price target. Recent news highlights Oracle's AI infrastructure expansion and partnership with OpenAI.
Outlook: Oracle's AI-driven growth and solid financials support long-term upside, but near-term risks include high debt levels and competitive pressures. The stock offers value for investors seeking exposure to enterprise software and cloud infrastructure, with earnings on June 10, 2026, as a key catalyst.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Oracle Corporation
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Read more on ORCL →
